Milestone Pharmaceuticals (MIST) Net Income Growth (1y) (2019 - 2022)
Milestone Pharmaceuticals (MIST) Net Income Growth (1y) (2019 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,831.58 Bn | 66,831.30 Bn | - | -0.46% |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - | - |
| 3 | Akari Therapeutics | 976.78 Bn | 976.78 Bn | - | - |
| 4 | BeOne Medicines | 471.48 Bn | 466.69 Bn | 1.35 Bn | 17,802.13% |
| 5 | Vertex Pharmaceuticals | 121.78 Bn | 114.53 Bn | 2.59 Bn | 59.59% |
| 6 | Regeneron Pharmaceuticals | 69.87 Bn | 61.12 Bn | 3.31 Bn | -10.08% |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn | 63.48% |
| 9 | Alnylam Pharmaceuticals | 37.54 Bn | 34.53 Bn | 959.66 Mn | 1,228.66% |
| 10 | Milestone Pharmaceuticals | 147.22 Mn | -36.99 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -5.66% |
| Jun 30, 2022 | -2,282.60% |
| Dec 31, 2021 | -94.83% |
| Sep 30, 2021 | -18.75% |
| Jun 30, 2021 | 105.93% |
| Mar 31, 2021 | 23.43% |
| Dec 31, 2020 | 52.61% |
| Sep 30, 2020 | 6.64% |
| Jun 30, 2020 | 4.97% |
| Mar 31, 2020 | -56.36% |
| Dec 31, 2019 | -88.21% |
| Sep 30, 2019 | -125.11% |
| Jun 30, 2019 | -280.55% |
| Mar 31, 2019 | -149.99% |